Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1998The Journal of Urology

Tamsulosin Treatment of 19,365 Patients With Lower Urinary Tract Symptoms: Does Co-Morbidity Alter Tolerability?

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMartin C. MichelJohannes Gutenberg University MainzLMLUDWIG MEHLBURGERBoehringer Ingelheim (Germany)HBHANS-ULRICH BRESSELBoehringer Ingelheim (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Michel et al. (1998) studied this question.

synapsesocial.com/papers/6a923bf1fd03cddea1962bd6https://doi.org/10.1016/s0022-5347(01)62787-3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical comparison of selective and non‐selective &agr; 1 A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses1997 · 140 citations
  2. 2Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia1998 · 369 citations
  3. 3Alpha-Blockade in the Treatment of Symptomatic Benign Prostatic Hyperplasia1995 · 85 citations
  4. 4Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.1983 · 185 citations